Clinical and Autoimmune Profile of Scleroderma Patients from Western India

Table 2

Distribution of autoantibodies in subgroups of scleroderma patients ().

Autoantibodies; (%)	Diffused; ()	Limited; ()	Overlap; ()
ANA; 94 (85.5%)	39; (86.7%)	28; (87.5%)	27; (81.8%)
Anti-Scl70 antibodies; 69 (62.7%)	34*; (75.6%)	15; (46.9%)	20; (60.6%)
Anti-centromere antibodies; 25 (22.7%)	04**; (9%)	12; (38%)	09; (27%)
AECA; 33 (30%)	09; (20%)	15; (48%)	09; (27%)
AKA; 45 (40.9%)	18; (40%)	10; (31%)	17; (51%)

, OR = 3.5030, and 95% CI = 1.3256–9.2570.
, OR = 0.1626, and 95% CI = 0.0465–0.5684.